EFFECT OF INTRAVITREAL TISSUE-PLASMINOGEN ACTIVATOR ON EXPERIMENTAL SUBRETINAL HEMORRHAGE

被引：55

作者：

COLL, GE

SPARROW, JR

MARINOVIC, A

CHANG, S

机构：

[1] Department of Ophthalmology, Cornell University Medical College, New York, NY

[2] St. Lukes-Roosevelt Hospital Center, New York, NY

来源：

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 1995年 / 15卷 / 04期

关键词：

INTRAVITREAL; SUBRETINAL HEMORRHAGE; TISSUE PLASMINOGEN ACTIVATOR;

D O I：

10.1097/00006982-199515040-00009

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose: To study the effect of intravitreally injected tissue plasminogen activator (tPA) in an experimental model of subretinal hemorrhage. Methods: Autologous blood was transsclerally injected into the subretinal space in 34 albino rabbits. One day later tPA was injected into the posterior vitreous in 24 eyes and saline was injected into 10 control eyes. Lysis of the subretinal blood was assessed ophthalmoscopically and retinal function was evaluated electroretinographically. Results: In all eyes in which tPA was injected intravitreally 1 day after subretinal injection of blood, the formed subretinal clot was not visible within 24 hours of treatment. Liquefied subretinal blood that formed from clot lysis disappeared within 6 days. Conversely, in all saline-injected control animals, the subretinal clots were unchanged at 24 hours and were observed for at least 3 days after injection. As a result of the presence of subretinal blood, scotopic electroretinogram amplitudes were markedly reduced in the tPA and saline-injected groups. In many eyes, blood migrated from the subretinal space into the vitreous, but it was detected later, was less severe, and cleared more rapidly after tPA injection. Conclusion: Intravitreal injection of tPA 1 day after subretinal injection of blood in rabbits facilitated more rapid lysis of the clotted blood, however, retinal damage was not prevented.

引用

页码：319 / 326

页数：8

共 27 条

[1]

Lewis H., Management of submacular hemorrhage, Medical and Surgical Retina: Advances, Controversies and Management, pp. 54-62, (1993)

[2]

Bennett S.R., Biodi C.F., Folk J.C., Klugman M., Factors prognostic of visual outcomes in patients with subretinal hemorrhage, Am J Ophthalmol, 109, pp. 33-37, (1990)

[3]

Glatt H., Machamer R., Experimental subretinal hemorrhage in rabbits, Am J Ophthalmol, 94, pp. 762-773, (1982)

[4]

Wade E.C., Flynn H.W., Olsen K.R., Subretinal hemorrhage management by pars plans vitrectomy and internal drainage, Arch Ophthalmol, 108, pp. 973-978, (1990)

[5]

Peyman G.A., Nelson N.C., Alturki W., Et al., Tissue plasminogen activator factor assisted removal of subretinal hemorrhage, Ophthalmol Surg, 22, pp. 575-582, (1991)

[6]

Hanscom T.A., Diddie K.R., Early surgical drainage of macular subretinal hemorrhage, Arch Ophthalmol, 105, pp. 1722-1723, (1987)

[7]

Johnson M.W., Olsen K.R., Hernandez E., Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage, Ophthalmol, 99, pp. 515-521, (1992)

[8]

Slusher M.M., Evacuation of submacular hemorrhage-technique and timing, Vitreoretinal Surgery and Technology, pp. 1-28, (1989)

[9]

de Juan E., Machamer R., Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration, Am J Ophthalmol, 105, pp. 25-29, (1988)

[10]

Vander J.F., Federman J.L., Greven C., Surgical removal of massive subretinal associated with age-related macular degeneration, Am J Ophthalmol, 98, pp. 23-27, (1991)

← 1 2 3 →